Western blot and RT-PCR analyses demonstrated that AUY922 increased the sensitivity of ccRCC cells to sunitinib by targeting the HIF-1α/VEGFA/VEGFR pathway. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.